This inventor holds 1 USPTO granted patent. Top assignees: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Xiamen University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xuerong Jia: Innovator in Coronavirus Detection
Introduction
Xuerong Jia is a notable inventor based in Beijing, China. He has made significant contributions to the field of biological sciences, particularly in the detection of viruses. His work has implications for public health and safety, especially in the context of emerging infectious diseases.
Latest Patents
Xuerong Jia holds a patent titled "Antigen for 2019 Novel Coronavirus and Detection Use Thereof." This patent represents a crucial advancement in the detection of the coronavirus, which has been pivotal during the global pandemic. His innovative approach aids in the rapid identification of the virus, contributing to timely responses in healthcare settings.
Career Highlights
Throughout his career, Xuerong Jia has worked with prominent organizations, including Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. and Xiamen University. His experience in these institutions has allowed him to collaborate with leading experts in the field and to further his research in virology and diagnostics.
Collaborations
Xuerong Jia has collaborated with Qiaoyun Shi, a fellow researcher, to enhance the development of diagnostic tools for viral infections. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Xuerong Jia's contributions to the field of coronavirus detection highlight his role as an important inventor in modern science. His patent and collaborations reflect a commitment to advancing public health through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile